KeraLink and CorneaGen – Two Forces Aligning for the Greater Good of Eye Care

On March 1, 2019, KeraLink transferred its domestic eye banking operations to another industry leader, CorneaGen. SC&H Capital facilitated this unique transaction which allowed KeraLink to pursue a new strategic vision – create more opportunities to restore sight to more people internationally.

Our latest Now to Next Podcast features a unique perspective from Doug Furlong, CEO, KeraLink, Monty Montoya, CEO CorneaGen, and Christopher Helmrath, Managing Director, SC&H Capital.

Learn more about this transaction in the full press release and please contact SC&H Capital if you have any questions.

Investment banking process